Stress versus depression

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 20, Issue 6, 1996, Pages 899-950

  Lechin, Fuad ^a,b,c   Van Der Dijs, Bertha ^a,b   Benaim, Mireya ^b  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b Hans Selye Institute of Stress   (Venezuela)

^c NONE   (Venezuela)

Author keywords

adrenaline; antidepressants; biological markers; clonidine test; colon motility; depression; dopamine; dysthymic depression; endogenous depression; epinephrine; exercise; free serotonin; hormones; noradrenaline; norepinephrine; oral glucose tolerance test; orthostasis; plasma catecholamines; plasma serotonin; platelet aggregability; platelet serotonin; stress

Indexed keywords

ADRENALIN; DOPAMINE; NORADRENALIN; SEROTONIN;

DEPRESSION; DYSTHYMIA; HUMAN; MALADJUSTMENT; NEUROCHEMISTRY; NEUROENDOCRINOLOGY; REVIEW; STRESS;

EID: 0030217895     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-5846(96)00075-9     Document Type: Review

References (215)

1. ABERG-WISTED, A., ROSS, S.B., JOSTELL, K.G. and SJOQUIST, B. (1982) A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings. Acta Psychiatr. Scand. 66: 66-82.
2. ANDREOLI, A., KELLER, S.E., RABAEUS, M., ZAUGG, L., GARRONE, G. and TABAN, C. (1992) Immunity, major depression, and panic disorder comorbidity. Biol. Psychiatry 31: 896-908.
3. ANISMAN, H. (1978) Neurochemical changes elicited by stress. In: Psychopharmacology of aversively motivated behavior, H. Anisman and G. Bignami (Eds.), pp 119-172, Plenum Press, New York.
4. ANISMAN, H., IRWIN, J. and SKLAR, L.S. (1979) Deficits of escape performance following catecholamine depletion: implications or behavior deficits induced by uncontrollable stress. Psychopharmacology 64: 163-170.
5. ANISMAN, H., PIZZINO, A., and SKLAR, L.S. (1980) Coping with stress, norepinephrine depletion and escape performance. Brain Res. 191: 583-588.
6. ANISMAN, H., RITCH, M. and SKLAR, L.S. (1981) Noradrenergic and dopaminergic interactions in escape behavior: analysis of uncontrollable stress effects. Psychopharmacology 74: 263-268.
7. ANISMAN, H. and SKLAR, L.S. (1979) Catecholamine depletion in mice upon reexposure to stress: mediation of the escape deficits produced by inescapable shock. J. Comp. Physiol. 93: 610-625.
8. ANISMAN, H., SUISSA, A. and SKLAR, L.S. (1980) Escape deficits produced by uncontrollable stress: antagonism by dopamine and norepinephrine agonists. Behav. Neurol. Biol. 28: 34-47.
9. ANISMAN, H. and ZACHARKO, R.M. (1982) Depression: the predisposing influence of stress. Behav. Brain Sci. 5: 89-137.
10. APRISON, M.H. and HINGTGEN, J.N. (1981) Hypersensitive serotonergic receptors: A new hypothesis for one subgroup of unipolar depression derived from an animal model. In: Serotonin: Current Aspects of Neurochemistry and Function, B. Haber, S. Gabay, M.R. Issidorides, S.G.A. Alivisatos, (Eds.), pp 627-656, Plenum Publishing Co., New York.
11. APRISON, M.H., HINGTGEN, J.N. and NAGAYAMA, M. (1982) Testing a new theory of depression with an animal model: Neurochemical-behavioural evidence for postsynaptic serotonergic receptor involvement. In: New vistas in depression, S. Langer, R. Takahashi, T. Segawa and M. Briley, (Eds.), pp 171-178, Pergamon Press, New York.
12. ARDLIE, N.G., CAMERON, H.A. and GARRETT, J. (1984) Platelet activation by circulating levels of hormones: a possible link in coronary heart disease. Thromb. Res. 36: 315-321.
13. AZORIN, J.M., KAREGE, F., MALLI, M., PRINGUEY, D., JOANNY, P. and TISSOT, R. (1988) Plasma 3,4-dihydrophenylethyleneglycol and 3-methoxy-4-hydroxy phenylethylene glycol as indicators of central noradrenergic activity. A comparative study on control subjects and depressed patients. Neuropsychobiology 20: 67-73.
14. BANKI, C.M., MOLNAR, G. and VOJNIK, M. (1991) Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression: psychopathological symptoms. J. Affective Dis. 3: 91-109.
15. BALDESSARINI, R.J. (1984) Treatment of depression by altering monoamine metabolism: precursors and metabolic inhibitors. Psychopharmacol. Bull. 20: 224-239.
16. BARABAN, F.M. and AGHAJANIAN, G.K. (1980) Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonist. Neuropharmacology 19: 355-363.
17. BENARROCH, E.E., BALDA, M.S., FINKELMAN, S. and NAHMOD, E. (1983) Neurogenic hypertension after depletion of norepinephrine in anterior hypothalamus induced by 6-hydroxydopamine administration into the ventral pons: Role of serotonin. Neuropharmacology 22: 29-34.
18. BENFIELD, P., HEEL, R.C. and LEWIS, S.P. (1986) Fluoxetine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic effects during depressive illness. Drugs 32: 481-508.
19. BERGER, M., DOERR, P., LUND, R., BRONISCH, T. and VON ZERSSEN, D. (1982) Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype? Biol. Psychiatry 17: 1217-1242.
20. BLACKARD, W. and HEIDINGSFELDER, S. (1968) Adrenergic receptor control mechanism for growth hormone secretion. J. Clin. Invest. 47: 1407-1414.
21. BOWER, M.B. (1972) Cerebrospinal fluid 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) following probenecid in unipolar depressives treated with amitriptyline. Psychopharmacology 23: 26-33.
22. BREIER, A., ALBUS, M., PICKAR, D., ZAHN, T.P., WOLKOWITZ, O.M. and PAUL, S.M. (1987) Controllable and uncontrollable stress in humans: alterations in mood and neuroendocrine and psychophysiological function. Am. J. Psychiatry 144: 1419-1425.
23. BURCHFIELD, S.R. (1979) The stress response: A new perspective. Psychosom. Med. 41: 661-672.
24. CABIB, S., KEMPF, E., SCHLEEF, C., OLIVEIRO, A. and PUGLISI-ALLEGRA, S. (1988) Effects of immobilization stress on dopamine and its metabolites in different brain areas of the mouse: Role of genotype and stress duration. Brain Res. 441: 153-160.
25. CABRERA, A., VAN DER DIJS, B., JIMENEZ, V., GUERRERO, H. and LECHIN, F. (1988) Plasma neurotransmitters profile in normal subjects. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7: (suppl. 1):Abst. 107.
26. CARAMONA, M.M. and SOARES DA SILVA, P. (1985) The effects of chemical sympathectomy on dopamine, noradrenaline and adrenaline content in some peripheral tissues. Br. J. Pharmacol. 86: 351-356.
27. CARROLL, B.J. (1982) Neuroendocrine diagnosis of depression: the dexamethasone suppression test. In: Treatment of depression: Old controversies and new approaches, P.J. Clayton, J. Barret, (Eds.), Raven Press, New York.
28. CHARNEY, D.S., HENINGER, G.R., STERNBERG, D.E., HAFSTAD, KM, GIDDINGS, S. and LANCIS, D.H. (1982) Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects. Arch. Gen. Psychiatry 39: 290-294.
29. CHECKLEY, S.A., SLADE, A.P. and SHUR, E. (1981) Growth hormone and other responses to clonidine in patients with endogenous depression. Br. J. Psychiatry 138: 51-55.
30. CIVEIRA, J., CERVERA, S. and GINER, J. (1990) Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain. Acta Psychiat. Scand. 82: (suppl. 360):48-49.
31. CLEMENTS-JEWERY, S. (1978) The development of cortical beta-adrenoceptor subsensitivity in the rat by chronic treatment with trazodone, doxepin and mianserine. Neuropharmacology 17: 779-781.
32. CROISET, G., HEIJNEN, C.J., VELDHUIS, H.D., DE WIED, D. and BALLIEUX, R.E. (1987) Modulation of the immune response by emotional stress. Life Sci. 40: 775-782.
33. CROSS, R.J. and ROSZMAN, T.L. (1988) Central catecholamine depletion impairs in vivo immunity but not in vitro lymphocyte activation. J. Neuroimmunology 19: 33-45.
34. DANTZER, R. and Kelley, K.W. (1989) Stress and immunity: An integrated view of relationships between the brain and the immune system. Life Sci. 44: 1995-2008.
35. DARKO, D.F., LUCAS, A.H., GILLIN, J.C., RISCH, S.C., GOLSHAN, S., HAMBURGER, R.N., SILVERMAN, M.B. and JANOWSKY, D.S. (1988) Age, cellular immunity and the HP axis in major depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 12: 713-720.
36. DAVIES, K.L., HOLLISTER, L.E., MATHE, A.A., DAVIS, B.M., ROTHPEARL, A.B., FAULL, K., HSIEH, J.Y.K., BARCHAS, J.D. and BERGER, P.A. (1981) Neuroendocrine and neurochemical measurements in depression. Am. J. Psychiatry 38: 1555-1562.
37. DAY, T.A. and WILLOUGHBY, J.O. (1980) Noradrenergic afferent to median eminence: Inhibitory role in the rythmic growth hormone secretion. Brain Res. 202: 335-345.
38. DE BOER, S.F., KOOPMANS, S.J., SLANGEN, J.L. and VAN DER GUGTEN, J. (1990) Plasma catecholamines, corticosterone and glucose responses to repeated stress in rats: effects of interstressor interval length. Physiol. Behav. 47: 1117-1124.
39. DELBENDE, C., CONTESSE, V., MOCAER, E., KAMOUN, A. and VAUDRY, H. (1991) The novel antidepressant, tianeptine, reduces stress-evoked stimulation of the hypothalamo-pituitary-adrenal axis. Eur. J. Pharmacol. 202: 391-396.
40. DEMONTIGNY, C. and BLIER, P. (1984) Effects of antidepressant treatments on 5HT neurotransmission: Electrophysiological and clinical studies. Adv. Biol. Psychiatry 39: 223-239.
41. DILSAVER, S.C. and COFFMAN, J.A. (1989) Cholinergic hypothesis of depression: A reappraisal. J. Clin. Pharmacol. 9: 173-179.
42. DIMSDALE, J.E. and MOSS, J. (1980) Plasma catecholamines in stress and exercise. JAMA 243: 340-345.
43. DUNN, A.J. (1988a) Stress-related changes in cerebral catecholamine and indoleamine metabolism: Lack of effect of adrenalectomy and corticosterone. J. Neurochem. 51: 406-412.
44. DUNN, A.J. (1988b) Changes in plasma and brain tryptophane, and brain serotonin and 5-hydroxyindoleacetic acid after footshock stress. Life Sci. 42: 1847-1853.
45. EDEN, S., BOILE, P. and MODIGH, K. (1979) Monoaminergic control of episodic growth hormone secretion in the rat: effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine and haloperidol. Endocrinology 105: 523-529.
46. ELLSWORTH, J.D., REDMOND, D.E. and ROTH, R.H. (1982) Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primates. Brain Res. 235: 115-124.
47. 2-receptors reflected in the growth hormone response to clonidine in reserpine pre-treated rats. Psychopharmacology (Berlin) 77: 327-331.
48. FUXE, K., ANDERSON, K., ENEROTH, P., SIEGEL, R.A. and AGNATI, L.F. (1983) Immobilization stress-induced changes in discrete catecholamine levels and turnover, their modulation by nicotine and relationship to neuroendocrine function. Acta Physiol. Scand. 117: 421-426.
49. FUXE, K., OGREN, S.O., AGNATI, L.F. and CALZA, L. (1982) Evidence for stabilization of cortical 5HT neurotransmission by chronic treatment with antidepressant drugs: Induction of a high and low affinity component in 3H-5HT binding sites. Acta Physiol. Scand. 114: 477-480.
50. FUXE, K., OGREN, S.O., AGNATI, L.F., ENEROTH, P., HOLM, A.C. and ANDERSSON, K. (1981) Long-term treatment with zimelidine leads to a reduction in 5-hydroxytryptamine neurotransmission within central nervous system of the mouse and rat. Neurosci. Lett. 21: 57-62.
51. FUXE, K., OGREN, S.O., AGNATI, L., GUSTAFSSON, J.A. and JONSSON, G. (1977) On the mechanisms of action of the antidepressant drugs amitriptyline and nortriptyline. Evidence for 5-hydroxytriptamine receptor blocking activity. Neurosci. Lett. 6: 339-343
52. GAMALLO, A., VILLANUA, A., TRANCHO, G. and FRAILE, A. (1986) Stress adaptation and adrenal activity in isolated and crowded rats. Physiol. Behav. 36: 217-221.
53. GEERTS, S., BRUYNOOGHE, F., and DE CUYPER, H. (1994) Moclobemide versus fluoxetine for major depressive episodes. Clin. Neuropharmacol. 17 (suppl 1): 14.
54. GIBBONS, R.D. and DAVIS, J.M. (1986) Consistent evidence for a biological subtype of depression characterized by low CSF-5-HIAA monoamine levels. Acta Psychiatr. Scand. 74: 8-12.
55. GOMEZ, F., LECHIN, A.E., JARA, H., JIMENEZ, V., CABRERA, A., GUERRERO, H., VAN DER DIJS, B. and LECHIN, F. (1988) Plasma neurotransmitters in anxiety patients. III Interamerican Congress of Clinical Pharmacological and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 4.
56. GLAVIN, G.B. (1985) Selective noradrenaline depletion markedly alters stress responses in rats. Life Sci. 37: 461-465.
57. GUELFI, J.D. and PAYAN, C., and FERMANIAN, J. (1992) Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial. Br. J. Psychiatry 160: 519-524.
58. HAFT, J.I. and ARKEL, Y.S. (1976) Effect of emotional stress on platelet aggregation in humans. Chest 70: 501-506.
59. HEINSBROEK, R.P.W., VAN HAAREN, F., FEENSTRA, M.G.P., BOON, P. and VAN DE POLL, N. E. (1991) Controllable and uncontrollable footshock and monoaminergic activity in the frontal cortex of male and female rats. Brain Res. 551: 247-255.
60. HELLHAMMER, D.H. (1983) Learned helplessness: An animal model revisited. In: The origins of depression, J. Agnst (Ed.), pp 147-161, Springer, Berlin.
61. HENDLEY, E.D., CIERPIAL, M.A. and MCCARTY, R. (1988) Sympathetic-adrenal medullary response to stress in hyperactive and hypertensive rats. Physiol. Behav. 44: 47-51.
62. HENINGER, G.R., CHARNEY, D.S., and STERNBERG, D.E. (1984) Serotonergic function in depression. Arch. Gen. Psychiatry 41: 398-402.
63. HERMAN, J.P., GUILLONNEAU, D., DANTZER, R., SCATTON, B., SMERDJIAN-ROUQUIER, L. and LE MOAL, M. (1982) Differential effects of inescapable foot-shocks and of stimuli previously paired with inescapable foot-shocks on dopamine turnover in cortical and limbic areas of the rat. Life Sci. 30: 2207-2214.
64. HSU, C.Y., KNAPP, D.R. and HALUSHKA, P.V. (1979) The effects of alpha adrenergic agents on human blood platelet aggregation. J. Pharmacol. Exp. Ther. 208: 366-372.
65. HUANG, Y.H. (1979) Net effect of acute administration of desipramine on the locus coeruleus-hippocampal system. Life Sci. 25: 739-746.
66. IMPERATO, A., PUGLISI-ALLEGRA, S., CASOLINI, P., ZOCCHI, A. and ANGELUCCI, L. (1989) Stress-induced enhancement of dopamine and acetylcholine release in limbic structures: role of corticosterone. Eur. J. Pharmacol. 165: 337-338.
67. IRWIN, J., AHLUWALIA, P., ZACHARKO, R.M. and ANISMAN, H. (1986) Central norepinephrine and plasma corticosterone following acute and chronic stressors: influence of social isolation and handling. Pharmacol. Biochem. Behav. 24: 1151-1154.
68. JARA, H., LECHIN, A.E., RADA, I., VILLA, S., CABRERA, A., GUERRERO, H., VAN DER DIJS, B. and LECHIN, F. (1988) Plasma neurotransmitters profile in duodenal ulcer patients. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 86.
69. KAHN, R.S., WETZLER, S., ASNIS, G.M., PAPOLOS, D. and VAN PRAAG, H.M. (1990) Serotonin receptor sensitivity in major depression. Biol. Psychiatry 28: 358-362.
70. KHANSARI, D.N., MURGO, A.J. and FAITH, R.E. (1990) Effects of stress on the immune system. Immunol. Today 11: 170-174.
71. KLIMEK, V. and MOGILNICKA, E. (1978) The influence of mianserin and danitracen on the disappearance of noradrenaline in the rat brain. Pol. J. Pharmacol. Pharmac. 30: 255-261.
72. KOBAYASHI, R.M., PALKOVITS, M., KIZER, J.S., JACOBOWITZ, D.M. and KOPIN, I.J. (1975) Selective alterations of catecholamines and tyrosine hydroxylase activity in the hypothalamus following acute and chronic stress. In: Catecholamines and stress, E. Usdin, R. Kvetnansky and I.J. Kopin (Eds.), pp 29-38, Pergamon Press, Oxford, UK.
73. KONARSKA, M., STEWART, R.E. and McCARTY, R. (1989) Habituation of sympathetic adrenal medullary responses following exposure to chronic intermittent stress. Physiol. Behav. 46: 255-261.
74. KOYAMA, T. and MELTZER, H.Y. (1986) A biochemical and neuroendocrine study of the serotonergic system in depression. In: New results in depression research , H. Hyppius (Ed.), pp 169-188, Springer Verlag, Berlin.
75. KRAEMER, G.W. and McKINNEY, W.T. (1979) Interactions of pharmacological agents which alter biogenic amine metabolism and depression: An analysis of contributing factor within a primate model of depression. J. Affect. Dis. 1: 33-39.
76. KVETNANSKY, R., MITRO, A., PALKOVITZ, M. and BROWNSTEIN, M. (1976) Catecholamines in individual hypothalamic nuclei in stressed rats. In: Catecholamines and stress, E. Usdin, R. Kvetnansky and I.J. Kopin (Eds.), p 29, Pergamon Press, New York.
77. KVETNANSKY, R., WEISS V.K., THOA, N.B. and KOPIN, I.J. (1979) Effects of chronic guanethidine treatment and adrenal medullectomy on plasma levels of catecholamines and corticosterone in forcibly immobilized rats. J. Pharmacol. Exp. Ther. 209: 287-291.
78. LAKE, C.R., PICKER, D., ZIEGLER, M.G., SLIPPER, S., SLATER, S. and MURPHY, D.L. (1982) High plasma norepinephrine levels in patients with major affective disorders. Am. J. Psychiatry 139: 1315-1321.
79. LAKE, C.R., ZIEGLER, M.G. and KOPIN, I.J. (1976) Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. Life Sci. 18: 1315-1321.
80. LaPIERRE, Y.D. (1994) Pharmacological therapy of dysthymia. Acta Psychiatr. Scand. 89 (Suppl. 383): 42-48.
81. LARSON, P.T., HJEMDAHL, P.J., OLSSON, G., EGBERG, N. and HORNSTRA, G. (1989) Altered platelet function during mental stress and adrenaline infusion in humans: Evidence for an increase aggregability in vivo as measured by filtragometry. Clin. Sci. 76: 369-376.
82. LECHIN, A.E., JARA, H., CABRERA, A., VILLA, S., JIMENEZ, V., GUERRERO, H., VAN DER DIJS, B. and LECHIN, F. (1988a) Plasma neurotransmitters profile in reactive hypoglycemia. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 111.
83. LECHIN, A.E., JARA, H., Rada I, VILLA, S., CABRERA, A., JIMENEZ, V., VAN DER DIJS, B. and LECHIN, F. (1988b) Plasma neurotransmitters profile in irritable bowel syndrome (IBS): diarrheic patients. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 88.
84. LECHIN, A.E., VARON, J., VAN DER DIJS, B. and LECHIN, F. (1994a) Plasma catecholamines and indoleamines during attacks and remission on severe bronchial asthma: possible role of stress. Am. J. Respir. Crit. Care Med. 149: A778.
85. LECHIN, A.E., VARON, J., VAN DER DIJS, B. and LECHIN, F. (1994b) Plasma neurotransmitters, blood pressure and heart rate during rest and exercise. Am. J. Respir. Crit. Care Med. 149: A482.
86. LECHIN, A.E., VILLA, S., JARA, H., CABRERA, A., JIMENEZ, V., VAN DER DIJS, B. and LECHIN, F. (1988c) Plasma neurotransmitters profile in bronchial asthma. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 10.
87. LECHIN, F., GOMEZ, F., VAN DER DIJS, B. and LECHIN, E. (1980a) Distal colon motility in schizophrenic patients. J. Clin. Pharmacol. 20: 459-465.
88. LECHIN, F. and VAN DER DIJS, B. (1984) Slow wave sleep (SWS), REM sleep (REMS) and depression. Res. Comm. Psychol. Psychiat. Behav. 9: 227-262.
89. LECHIN, F. and VAN DER DIJS, B. (1982) Intestinal pharmacomanometry as a guide to psychopharmacological therapy. In: Clinical Pharmacology and Therapeutics, M. Velazco (Ed.), pp 166-173, International Congress Series No 604, Excerpta Medica, Amsterdam.
90. LECHIN, F. and VAN DER DIJS, B. (1981a) Intestinal pharmacomanometry and glucose tolerance: evidence for two antagonistic dopaminergic mechanisms in the human. Biol. Psychiatry 16: 969-986.
91. LECHIN, F. and VAN DER DIJS, B. (1981b) Colon motility and psychological traits in irritable bowel syndrome. Dig. Dis. Sci. 26: 474-475.
92. LECHIN, F. and VAN DER DIJS, B. (1981c) Noradrenergic or dopaminergic activity in chronic schizophrenia? Br. J. Psychiatry 139: 472.
93. LECHIN, F. and VAN DER DIJS, B. (1981d) Clonidine therapy for psychosis and tardive dyskinesia. Am. J. Psychiatry 138: 390.
94. LECHIN, F. and VAN DER DIJS, B. (1980) Physiological, clinical and therapeutical basis of a new hypothesis for headache. Headache 20: 77-83.
95. LECHIN, F. and VAN DER DIJS, B. (1977) A new treatment for headache. Pathophysiologic considerations. Headache 16: 318-321.
96. LECHIN, F., VAN DER DIJS, B., ACOSTA, E., GOMEZ, F., LECHIN, E. and AROCHA, L. (1983a) Distal colon motility and clinical parameters in depression. J. Affect. Dis. 5: 19-26.
97. LECHIN, F., VAN DER DIJS, B., AMAT, J., LECHIN, A.E., CABRERA, A., LECHIN, M.E., GOMEZ, F., AROCHA, L. and JIMENEZ, V. (1988a) Definite and sustained improvement with pimozide of two patients with severe trigeminal neuralgia: Some neurochemical, neurophysiological and neuroendocrinological findings. J. Med. 19: 243-256.
98. LECHIN, F., VAN DER DIJS, B., AMAT, J. and LECHIN, M.E. (1989a) Central neuronal pathways involved in depressive syndrome: Experimental findings. In: Neurochemistry and clinical disorders: Circuitry of some psychiatric and psychosomatic syndromes, F. Lechin and B. van der Dijs (Eds.), pp 65-89, CRC Press, Boca Raton, FL.
99. LECHIN, F., VAN DER DIJS, B., AZOCAR, J., AMAT, J., VITELLI-FLOREZ, G., MARTINEZ, C., LECHIN-BAEZ, S., JIMENEZ, V., CABRERA, A., CARDENAS, M. and VILLA, S. (1987a) Stress, immunology and cancer: Effect of psychoactive drugs. Arch. Ven. Farmac. Terap. 6: 28-43.
100. LECHIN, F., VAN DER DIJS, B., AZOCAR, J., VITELLI, G., LECHIN, S., VILLA, S., JARA, H. and CABRERA, A. (1988b) Neurochemical and immunological profiles of three clinical stages in 50 advanced cancer patients. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 39.
101. LECHIN, F., VAN DER DIJS, B., BAEZ-LECHIN, S., LECHIN, A.E., OROZCO, B., LECHIN, M.E., RADA, I., JARA, H., GOMEZ, F., CABRERA, A., JIMENEZ, V., AROCHA, L. and LEON, G. (1994a) Two types of irritable bowel syndrome: Pathophysiologic and pharmacological considerations. Arch. Ven. Farmacol. Terap. 12: 105-114.
102. LECHIN, F., VAN DER DIJS, B., BENTOLILA, A. and PEÑA, F. (1977a) The spastic colon syndrome: Pathophysiological considerations. J. Clin. Pharmacol. 17: 431-440.
103. LECHIN, F., VAN DER DIJS, B., BENTOLILA, A. and PEÑA, F. (1977b) Antidiarrheal effects of dihydroergotamine. J. Clin. Pharmacol. 17: 339-349.
104. LECHIN, F., VAN DER DIJS, B., GOMEZ, F., ACOSTA, E. and AROCHA, L. (1982a) On the use of clonidine and thioproperazine in a woman with Gilles de La Tourette's disease. Biol. Psychiatry 17: 103-108.
105. LECHIN, F., VAN DER DIJS, B., GOMEZ, F., ACOSTA, E. and AROCHA, L. (1982b) Comparison between the effects of d-amphetamine and fenfluramine on distal colon motility in non-psychotic patients. Res. Comm. Psychol. Psychiat. Behav. 7: 411-430.
106. LECHIN, F., VAN DER DIJS, B., GOMEZ, F., AROCHA, L. and ACOSTA, E. (1982c) Effects of d-amphetamine, clonidine and clonazepam on distal colon motility in non-psychotic patients. Res. Comm. Psychol. Psychiat. Behav. 7: 385-410.
107. LECHIN, F., VAN DER DIJS, B., GOMEZ, F., AROCHA, L., ACOSTA, E. and LECHIN, E. (1983b) Distal colon motility as a predictor of antidepressant response to fenfluramine, imipramine and clomipramine. J. Affect. Dis. 5: 27-35.
108. LECHIN, F., VAN DER DIJS, B., GOMEZ, F., LECHIN, A.E., ACOSTA, E. and AROCHA, L. (1989b) Biological markers in the assessment of central autonomic nervous functioning: an approach to the diagnosis of some psychiatric and psychosomatic syndromes. In: Neurochemistry and clinical disorders: circuitry of some psychiatric and psychosomatic syndromes, F. Lechin and B. van der Dijs (Eds.), pp 151-226, CRC Press, Boca Raton, FL.
109. LECHIN, F., VAN DER DIJS, B., GOMEZ, F., LECHIN, E., ORAMAS, O. and VILLA, S. (1983c) Positive symptoms of acute Psychosis: Dopaminergic or noradrenergic overactivity? Res. Comm. Psychol. Psychiat. Behav. 8: 23-54.
110. LECHIN, F., VAN DER DIJS, B., GOMEZ, F., VALLS, J.M., ACOSTA, E. and AROCHA, L. (1980b) Pharmacomanometric studies of colonic motility as a guide to the chemotherapy of schizophrenia. J. Clin. Pharmacol. 20: 664-671.
111. LECHIN, F., VAN DER DIJS, B., GOMEZ, F., VILLA, S., CABRERA, A., JIMENEZ, V., GUERRERO, H. and LECHIN, A.E. (1988c) Plasma neurotransmitter profiles in depressive syndromes. Abstracts of the III Interamerican Congress of Clinical Pharmacology and Therapeutics and the XII Latinamerican Congress of Pharmacology. Arch. Ven. Farm. Terap. 7 (suppl 1): Abst. 7.
112. LECHIN, F., VAN DER DIJS, B., INSAUSTI, C.L. and GOMEZ, F. (1982d) Treatment of ulcerative colitis with thioproperazine. J. Clin. Gastroenterol. 4: 445-449.
113. LECHIN, F., VAN DER DIJS, B., INSAUSTI, C.L., GOMEZ, F., VILLA, S., LECHIN, A.E., AROCHA, L., and ORAMAS, O. (1985a) Treatment of ulcerative colitis with clonidine. J. Clin. Pharmacol. 25: 219-226.
114. LECHIN, F., VAN DER DIJS, B., JACKUBOWICZ, D., CAMERO, R.E., LECHIN, S., VILLA, S., REINFELD, B. and LECHIN, M.E. (1987b) Role of stress in the exacerbation of chronic illness: Effects of clonidine administration on blood pressure and plasma norepinephrine, cortisol, growth hormone and prolactin concentrations. Psychoneuroendocrinology 12: 117-129.
115. LECHIN, F., VAN DER DIJS, B., JACKUBOWICZ, D., CAMERO, R.E., VILLA, S., AROCHA, L. and LECHIN, A.E.. (1985b) Effects of pressure, clonidine on blood noradrenaline, cortisol, growth hormone, and prolactin plasma levels in high and low intestinal tone depressed patients. Neuroendocrinology 41; 156-162.
116. LECHIN, F., VAN DER DIJS, B., JACKUBOWICZ, D., CAMERO, R.E., VILLA, S., LECHIN, E. and GOMEZ, F.. (1985c) Effects of clonidine on blood pressure, noradrenaline, cortisol, growth hormone, and prolactin plasma levels in high and low intestinal tone subjects. Neuroendocrinology 40: 253-261
117. LECHIN, F., VAN DER DIJS, B., LECHIN, A.E., OROZCO, B., LECHIN, M.E., BAEZ, S., RADA, I., LEON, G. and ACOSTA, E. (1994b) Plasma neurotransmitters and cortisol in chronic illness: Role of stress. J. Med. 25: 181-192.
118. LECHIN, F., VAN DER DIJS, B., LECHIN, A.E., LECHIN, M.E., COLL-GARCIA, E., JARA, H., CABRERA, A., JIMENEZ, V., GOMEZ, F., TOVAR, D., RADA, Y. and AROCHA, L. (1991) Doxepin therapy for postprandial symptomatic hypoglycemic patients: Neurochemical, hormonal and metabolic disturbances. Clin. Sci. 80: 373-384.
119. LECHIN, F., VAN DER DIJS, B., LECHIN, A.E., OROZCO, B., LECHIN, M.E., BAEZ-LECHIN, S., RADA, I., LEON, G., GARCIA, Z. and JIMENEZ, V. (1996a) Plasma neurotransmitters, blood pressure and heart rate during supine-resting, orthostasis and moderate exercise stress test in healthy humans before and after the parasympathetic blockade with atropine. Clin. Exp. Physiol. Pharmacol. (In press).
120. LECHIN, F., VAN DER DIJS, B. and LECHIN, E. (1979a) The autonomic nervous system: Physiological basis of psychosomatic therapy, Chapter VIII, pp 119-149, Editorial Cientifico-Medica, Barcelona, España.
121. LECHIN, F., VAN DER DIJS, B. and LECHIN, E. (1979b) The autonomic nervous system: Physiological basis of psychosomatic therapy, Chapter V, pp 65-72, Editorial Cientifico-Medica, Barcelona, España.
122. LECHIN, F., VAN DER DIJS, B., LECHIN, E., PEÑA, F. and BENTOLILA, A. (1978) The noradrenergic and dopaminergic blockades: A new treatment for headache. Headache 18: 69-74.
123. LECHIN, F., VAN DER DIJS, B., LECHIN, M.E., BAEZ, S., JARA, H., LECHIN, A, OROZCO, B., RADA, I., CABRERA, A., JIMENEZ, V. and LEON, G. (1992a) Effects of an oral glucose load on plasma neurotransmitters in humans: Involvement of REM sleep? Neuropsychobiology 26: 4-11.
124. LECHIN, F., VAN DER DIJS, B., LECHIN, M.E., JARA, H., LECHIN, A., BAEZ, S., OROZCO, B., RADA, I., CABRERA, A., AROCHA, L., JIMENEZ, V. and LEON, G. (1993) Plasma neurotransmitters throughout oral glucose tolerance test in non-depressed essential hypertension patients. Clin. Exper. Hypertension 15: 209-240.
125. LECHIN, F., VAN DER DIJS, B., LECHIN, M.E., AMAT, J., LECHIN, A.E., CABRERA, A., GOMEZ, F., ACOSTA, E., AROCHA, L., VILLA, S. and JIMENEZ, V. (1989c) Pimozide therapy for trigeminal neuralgia. Arch. Neurology 46: 960-963.
126. LECHIN, F., VAN DER DIJS, B., LECHIN, M.E., JARA, H., LECHIN, A.E., CABRERA, A., RADA, I., OROZCO, B., JIMENEZ, V. and VALDERRAMA, T. (1992b) Dramatic improvement with clonidine of acute pancreatitis showing raised catecholamines and cortisol plasma levels: Case report of five patients. J. Med. 23: 339-351.
127. LECHIN, F., VAN DER DIJS, B., LECHIN, S., VITELLI-FLOREZ, G., LECHIN, M.E. and CABRERA, A. (1989d) Neurochemical, hormonal and immunological views of stress: clinical and therapeutic implications in Crohn's disease and cancer. In: Recent advances in pharmacology and therapeutics, M. Velazco (Ed.), pp 57-70, International Congress Series 839, Excerpta Medica, Amsterdam.
128. LECHIN, F., VAN DER DIJS, B., OROZCO, B., LECHIN, A.E., BAEZ, S., LECHIN, M.E., RADA, I., ACOSTA, E., AROCHA, L., JIMENEZ, V., LEON, G. and GARCIA, Z. (1995a) Plasma neurotransmitters, blood pressure and heart rate during supine-resting, orthostasis and moderate exercise in dysthymic depressed patients. Biol. Psychiatry 37: 884-891.
129. LECHIN, F., VAN DER DIJS, B., OROZCO, B., LECHIN, M.E., BAEZ, S., LECHIN, A.E., RADA, I., ACOSTA, E., AROCHA, L., JIMENEZ, V., LEON, G. and GARCIA, Z. (1995b) Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients. Biol. Psychiatry 38: 166-173.
130. LECHIN, F., VAN DER DIJS, B., OROZCO, B., LECHIN, A.E., BAEZ, S., LECHIN, M.E., BENAIM, M., ACOSTA, E., AROCHA, L., JIMENEZ, V., LEON, G. and GARCIA, Z. (1996b) Plasma neurotransmitters, blood pressure and heart rate during supine-resting, orthostasis and moderate exercise in severely ill patients: A model of failing to cope with stress. Psychother. Psychosom. 65: (In Press).
131. LECHIN, F., VAN DER DIJS, B., OROZCO, B., LECHIN, M.E. AND LECHIN, A.E. (1996c) Increased free-serotonin plasma levels in symptomatic asthmatic patients. Ann. Allergy Asthma Immunol. (In Press).
132. LECHIN, F., VAN DER DIJS, B., RADA, I., JARA, H., LECHIN, A.E., CABRERA, A., LECHIN, M.E., JIMENEZ, V., GOMEZ, F., VILLA, S., ACOSTA, E. and AROCHA, L. (1990a) Plasma neurotransmitters and cortisol in duodenal ulcer patients: Role of stress. Dig. Dis. Sci. 35: 1313-1319.
133. LECHIN, F., VAN DER DIJS, B., VILLA, S., JARA, H., RADA, I., LECHIN, M.E., JIMENEZ, V. and GOMEZ, F. (1988d) Plasma neurotransmitters profile in chronic illness. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 38.
134. LECHIN, F., VAN DER DIJS, B., VITELLI-FLOREZ, G., BAEZ, S., LECHIN, M.E., LECHIN, A.E., OROZCO, B., RADA, I., LEON, G. and JIMENEZ, V. (1994c) Peripheral blood immunological parameters in long-term benzodiazepine users. Neuropharmacology 17: 63-72.
135. LECHIN, F., VAN DER DIJS, B., VITELLI-FLOREZ, G., LECHIN-BAEZ, S., AZOCAR, J., CABRERA, A., LECHIN, A.E., JARA, H., LECHIN, M.E., GOMEZ, F. and AROCHA, L. (1990b) Psychoneuroendocrinological and immunological parameters in cancer patients: Involvement of stress and depression. Psychoneuroendocrinology 15: 435-451.
136. LECHIN, M.E., JARA, H., VILLA, S., GOMEZ, F., CABRERA, A., GUERRERO, H., VAN DER DIJS, B. and LECHIN, F. (1988a) Plasma neurotransmitters profile in somatoform disorders. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 2.
137. LECHIN, M.E., JARA, H., RADA, I., VILLA, S., CABRERA, A., JIMENEZ, V., VAN DER DIJS, B. and LECHIN, F. (1988b) Plasma neurotransmitters profile in irritable bowel syndrome (IBS): Spastic colon. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 87.
138. LECHIN, M.E., JARA, H., VILLA, S., GOMEZ, F., JIMENEZ, V., CABRERA, A., VAN DER DIJS, B. and LECHIN, F. (1988c) Plasma neurotransmitters profile in tension headache. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 1.
139. LECHIN, M.E., VILLA, S., RADA, I., JARA, H., CABRERA, A., JIMENEZ, V., VAN DER DIJS, B. and LECHIN, F. (1988d) Plasma neurotransmitters profile in reflux esophagitis. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 85.
140. LECHIN, S., VITELLI, G., MARTINEZ, C., FERNANDEZ, M., CABRERA, A., VAN DER DIJS, B., AZOCAR, J. and LECHIN, F. (1988) Plasma neurotransmitters, lymphocyte subpopulations and natural killer cell activity in terminal cancer patients. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 37.
141. LEONARD, B. E. and KAFOE, W. (1976) A comparison of acute and chronic effects of four antidepressant drugs on the turnover of serotonin, dopamine and noradrenaline in the rat brain. Biochem. Pharmacol. 25: 1939-1942.
142. LEVINE, S.P., TOWELL, B.L., SUAREZ, A.M., KNIERIEM, L.K., HARRIS, M.M. and GEORGE, J.N. (1985) Platelet activation and secretion associated with emotional stress. Circulation 71: 1129-1134.
143. LIANG-FU, T. (1979) 5-Hydroxytryptamine uptake inhibitors block para-methoxyamphetamine-induced 5HT release. Brit. J. Pharmacol. 66: 185-190.
144. LUCKI, Y. and FRAZER, A. (1985) Performance and extinction of lever press behavior following chronic administration of desipramine to rats. Psychopharmacology 85: 253-259.
145. MAES, M., LAMBRECHTS, J., SUY, E., VANDERVORST, C. and BOSMANS, E. (1994) Absolute number and percentage of circulating natural killer, non-MHC-restricted T cytotoxic, and phagocytic cells in unipolar depression. Biol. Psychiatry 29: 157-163.
146. MAES, M., MELTZER, H., JACOBS, J., SUY, E., CALABRESE, J., MINNER, B. and RAUS, J. (1993) Autoimmunity in depression: Increased antiphospholipid autoantibodies. Acta Psychiatr. Scand. 87: 160-166.
147. MAIER, S.F. (1984) Learned helplessness and animal models of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 8: 435-446.
148. MAJ, J. (1978) Pharmacological spectrum of some new antidepressants. In: Advances in Pharmacology and Therapeutics, C. Dumond (Ed.), pp 161-170, Pergamon Press, New York.
149. MATUSSEK, N., ACKENHEIL, M., HIPPIUS, H., MULLER, F., CHROEDER, H.T., SCHULTES, H. and WASILEWSKI, B. (1980) Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiat. Res. 2: 25-36.
150. McWILLIAM, J.R. and MELDRUM, B.S. (1983) Noradrenergic regulation of growth hormone in the baboon. Endocrinology 112: 254-259.
151. MELTZER, H.Y. and LOWY, M.T. (1987) The serotonin hypothesis of depression. In: Psychopharmacology: The third generation of progress, H.Y. Meltzer (De.), pp 513-526, Raven Press, New York.
152. MORMEDE, P., DANTZER, R., MICHAUD, B., KELLEY, K.W. and Le MOAL, M. (1988) Influence of stressor predictability and behavioral control on lymphocyte reactivity, antibody responses and neuroendocrine activation in rats. Physiol. Behav. 43: 577-583.
153. MORRIS, J.B. and BECK, A.T. (1974) The efficacy of antidepressant drugs. Arch. Gen. Psychiatry 30: 667-674.
154. MURPHY, D.L., CAMPBELL, Y. and COSTA, J.L. (1978) Current status of indoleamine hypothesis of the affective disorders. In: Psychopharmacology: A generation of progress, M.A. Lipton, A. DiMascio and K.F. Killam (Eds.), pp 1235-1248, Raven Press, New York.
155. NAGAYAMA, H., HINGTGEN, J.N. and APRISON, M.H. (1981) Postsynaptic action by four antidepressive drugs in an animal model of depression. Pharmac. Biochem. Behav. 15: 650-655.
156. NATELSON, B.H., CREIGHTON, D., McCARTY, R., TAPP, W.N., PITMAN, D. and OTTENWELLER, J.E. (1987) Adrenal hormonal indices of stress in laboratory rats. Physiol. Behav. 39: 117-125.
157. NATELSON, B.H., OTTENWELLER, J.E., COOK, J.A., PITMAN, D., McCARTY, R. and TAPP, W.N. (1988) Effect of stressor intensity on habituation of the adrenocortical stress response. Physiol. Behav. 43: 41-46.
158. NIELSEN, M. and BRAESTRUP, C. (1977) Chronic treatment with desipramine caused a sustained decrease of 3,4-dihydroxyphenylglycol-sulfate and total 3-methoxy-4-hydroxyphenylglycol in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 300: 87-92.
159. NYBAECK, H.V., WALTERS, J.R. and AGHAJANIAN, G.K. (1975) Tricyclic antidepressants: effects on the firing rate of brain noradrenergic neurons. Eur. J. Pharmacol. 32: 302-312.
160. OGREN, S.O., FUXE, K., ARCHER, T., JOHANSSON, G. and HOLM, A.C. (1982) Behavioral and biochemical studies on the effects of acute and chronic administration of antidepressant drugs on central serotonergic receptor mechanisms. In: New vistas in depression, S. Langer, R. Takahashi, T. Segawa and M. Briley (Eds), pp 171-178, Pergamon Press, New York.
161. OGREN, S.O., FUXE, K., AGNATI, L.F., GUSTAFSSON, J.A., JONSSON, G. and HOLM, A.C. (1979) Reevaluation of the indoleamine hypothesis of depression: evidence for a reduction of functional activity of central 5HT systems by antidepressant drugs. J. Neural. Transm. 46: 85-103.
162. OTTENWELLER, J.R., NATELSON, B.H., PITMAN, D.L. and DRASTAL, S.D. (1989) Adrenocortical and behavioral responses to repeated stressors: toward an animal model of chronic stress and stress-related mental illness. Biol. Psychiatry 26: 829-841.
163. RUBIN, R.T., POLAND, R.E. and HAYS, S.E. (1979) Psychoneuroendocrine research in endogenous depression: A review. In: Biological psychiatry today, J. Obiols, C. Ballus, E. Gonzalez Monclus and J. Pujol (Eds.), pp 684-688, Elsevier Publishers, Amsterdam.
164. SACHSER, N. (1987) Short-term responses of plasma norepinephrine, epinephrine, glucocorticoid and testosterone titers to social and non-social stressors in male guinea pigs of different social status. Physiol. Behav. 39: 11-20.
165. SCHATZBERG, A.F. (1978) Classification of depressive disorders. In: Depression, Biology, Psychodynamics and Treatment, J.O. Cole, A.F. Schatzberg and S.H. Frazier (Eds.), pp 13-40, Plenum Press, New York.
166. SCHILDKRAUT, J.J., ORSULAK, P.J. and GUDEMAN, J.E. (1977) Recent studies of the role of catecholamines in the pathophysiology and classification of depressive disorders. In: Neuroregulators and psychiatric disorders, J.J. Schildkraut, and P.J. Orsulak (Eds.), pp 122-128, Oxford Press, New York.
167. SCUVEE-MOREAU, J.J. and DRESSE, A.L. (1979) Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and raphe dorsalis neurons of the rat. Eur. J. Pharmacol. 57: 219-225.
168. SEGAL, M. (1979) Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on responses to noxious stimuli. J. Physiol. 286: 401-415.
169. SHERMAN, A.D. and PETTY, F. (1980) Neurochemical basis of the action of antidepressants on learned helplessness. Behav. Neural. Biol. 30: 119-134.
170. SIEVER, L.J., RISCH, S.C., and MURPHY, D.L. (1981) Central cholinergic-adrenergic imbalance in the regulation of affective state. Psychiat. Res. 4: 108-114.
171. 2-adrenergic agonist clonidine. Biol. Psychiat. 19: 131-156.
172. SIEVER, L.J., UHDE, T.W., SILBERMAN, E.K., JIMERSON, D.G., ALOI, J.A., POST, R.M. and MURPHY, D.L. (1982) Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiat. Res. 6: 171-183.
173. SOURKES, T.L. (1985) Neurotransmitters and central regulation of adrenal functions. Biol. Psychiatry 20: 182-191.
174. STEPLEWSKI, Z., VOGEL, W.H., EHYA, H., POROPATICH, C. and McDONALD-SMITH, J. (1985) Effects of restraint stress or inoculated tumor growth and immune response in rats. Cancer Res. 45: 5128-5133.
175. STODDARD, S.L., BERGDALL, V.K., TOWSEND, D.W. and LEVIN, B.E. (1986) Plasma catecholamines associated with hypothalamically-elicited defense behavior. Physiol. Behav. 36: 867-873.
176. SUGRUE, M.F. (1980) Changes in rat brain monoamine turnover following chronic antidepressant administration. Life Sci. 26: 423-429.
177. PAVLIDIS, N. and CHIRIGOS, M. (1980) Stress-induced impairment of macrophage tumoricidal function. Psychosom. Med. 42: 47-54.
178. PAYKEL, E.S. (1990) Monoamine oxidase inhibitors: When should they be used? In: Dilemma and difficulties in the management of psychiatric patients, K. Hawton and P. Cowen (Eds.), pp 17-30, Oxford University Press, Oxford.
179. PETTY, F. and SHERMAN, A.D. (1983) Learned helplesness induction decreases in vivo cortical serotonin release. Pharmac. Biochem. Behav. 18: 649-650.
180. PORSOLT, R.D., ANTON, G., BLAVET, N. and JALFRE, M. (1978) Behavioral despair in rats: A new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47: 379-391.
181. PRZEGALINSKI, E., KORDECKA-MAGIERA, A., MOGILNICKA, E. and MAJ, J. (1981) Chronic treatment with some atypical antidepressant increases the brain level of 3-methoxy-4-hydroxyphenylglycol (MHPG) in rats. Psychopharmacology 74: 187-190.
182. PUJOL, J.F., KEANE, P., McRAE, A., LEWIS, B.D. and RENAUD, B. (1978) Biochemical evidence for serotonergic control of the locus coeruleus. In: Interactions between putative neurotransmitters in the brain, S. Garattini, J.F. Pujol and R. Samanin (Eds.), pp 401-410, Raven Press, New York.
183. QUITKIN, F.M., HARRISON, W.M., STEWART, J.W., McGRATH, P.J., TRICAMO, E., OCEPEK-WELIKSON, K., RABKIN, J.G., WAGER, S.G., NUNES, E. and KLEIN, D.F. (1991) Response to phenelzine and imipramine in placebo responders with atypical depression. Arch. Gen. Psychiatry 48: 319-323.
184. RAITERI, M., ANGELLINI, F. and BERTOLLINI, A. (1976) Comparative study of the effects of mianserin, a tetraccyclic antidepressant, and of imipramine on uptake and release of neurotransmitters in synaptosomes. J. Pharm. Pharmacol. 28: 483-488.
185. RIMON, R., JAASKELAINEN, J. and KAARTINEN, P. (1993) Moclobemide versus imipramine in depressed outpatients: A double-blind multicentre study. Int. Clin. Psychopharmacol. 7: 141-148.
186. RODRIGUEZ-ECHANDIA, E.L., BROITMAN, S.T. and FOSCOLO, M.R. (1987) Effect of the chronic ingestion of chlorimipramine on the hole board response to acute stresses in male rats. Pharmacol. Biochem. Behav. 26: 207-210.
187. ROFFMAN, M., KLING, M.A., CASSENS, G., ORSULAK, P.J., REIGLE, T.G. and SCHILDKRAUT, J.J. (1977) The effects of acute and chronic administration of tricyclic antidepressants of MHPG-SO4 in rat brain. Comm. Psychopharmacol. 1: 195-206.
188. ROSEMBAUM, A.H., SCHATZBERG, A.F., MARUTA, T., ORSYULAK, P.J., COLE, J.O., GRAB, E.L. and SCHILDKRAUT, J.J. (1980) MHPG as a predictor of antidepressant response to imipramine and maprotiline. Am. J. Psychiat. 137: 1090-1097.
189. ROTH, K.A., MEFFORD, I.M. and BARCHAS, J.D. (1982) Epinephrine, norepinephrine, dopamine, and serotonin: Differential effects of acute and chronic stress on regional brain amines. Brain Res. 239: 417-424.
190. ROY, A., PICKAR, D., LINNOILA, M. and POTTER, W.Z. (1985) Plasma norepinephrine in affective disorders: Relationship to melancholia. Arch. Gen. Psychiatry 42: 1181-1185.
191. SULSER, F. and MOBLEY, P.L. (1981) Regulation of central noradrenergic receptor function: new vistas on the mode of action of antidepressant treatments. In: Neuroreceptors: Basic clinical aspects, E. Usdin, W. B. Bunney and J.M. Davis (Eds.), pp 55-83, John Willey & Sons Inc., New York.
192. SWENSON, R.M. and VOGEL, W.H. (1983) Plasma catecholamine and corticosterone as well as brain catecholamine changes during coping in rats exposed to stressful footshock. Pharmacol. Biochem. Behav. 18: 689-693.
193. TANAKA, M., IDA, Y., TSUDA, A., TSUJIMARU, S., SHIRAO, Y. and OGUCHI, M. (1989) Metenkephalin, injected during the early phase of stress, attenuates stress-induced increases in noradrenaline release in rat brain regions. Pharmacol. Biochem. Behav. 32: 791-795.
194. TARGUM, S.D. (1984) Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse. Biol. Psychiatry 19: 305-318.
195. TECOMA, E.S. and HUEY, L.Y. (1985) Psychic distress and the immune response. Life Sci. 36: 1799-1812.
196. THIERRY, A.M., TASSIN, J.P., BLANC, G. and GLOWINSKI, J. (1976) Selective activation of the mesocortical dopaminergic system by stress. Nature 263: 242-244.
197. TISSARI, A.H., ARGIOLAS, A., FADDA, F., SERRA, G. and GESSA, G.L. (1979) Foot-shock stress accelerates non-striatal dopamine synthesis without activating tyrosine hydroxylase. Naunyn-Schmiedeberg's Arch. Pharmacol. 308: 155-157.
198. TONNESEN, E., HUTTEL, M.S., CHRISTENSEN, N.J. and SCHMITZ, O. (1984) Natural killer cell activity in patients undergoing upper abdominal surgery: Relationship to the endocrine stress response. Acta Anaesthesiol. Scand. 28: 654-660.
199. VAN DER DIJS, B., LECHIN, A.E., VILLA, S., GOMEZ, F., CABRERA, A., JIMENEZ, V., GUERRERO, H. and LECHIN, F. (1988a) Plasma neurotransmitters profile in cluster headache. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 3.
200. VAN DER DIJS, B., LECHIN, S., VITELLI, G., CABRERA, A., FERNANDEZ, M., MARTINEZ, C., AZOCAR, J. and LECHIN, F. (1988b) Plasma neurotransmitters, lymphocyte subpopulations and natural killer cell activity in progressive cancer patients. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 35.
201. VAN DER DIJS, B., LECHIN, S., VITELLI, G., CABRERA, A., FERNANDEZ, M., MARTINEZ, C., AZOCAR, J. and LECHIN, F. (1988c) Plasma neurotransmitters, lymphocyte subpopulations and killer cell activity in short term symptomless cancer patients. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 34.
202. VESIFELD, I.L., VASILIJIEV, V.N. and ILJICHEVA, R.F. (1976) Relationship of catecholamines, histamine and serotonin in men under different kind of stress. In: Catecholamines and stress, E. Usdin, R. Kvetnansky and I.J. Kopin (Eds.), pp 527-534, Pergamon Press, Oxford, UK.
203. VETULANI, J., ANTKIEWICZ-MICHALUK, L. and ROKOSZ-PELC, A. (1984) Chronic administration of antidepressant drugs increased the density of cortical (3H)-prazosin binding site in the rat. Brain Res. 310: 360-362.
204. VITELLI, G., LECHIN, S., CABRERA, A., FERNANDEZ, M., AZOCAR, J., VAN DER DIJS, B. and LECHIN, F. (1988) Plasma neurotransmitters, lymphocyte subpopulations and natural killer cell activity in long term symptomless cancer patients. III Interamerican Congress of Clinical Pharmacology and Therapeutics. Arch. Ven. Farm. Terap. 7 (suppl. 1): Abst. 36.
205. VOGEL, G.W. (1975) A review of REM sleep deprivation. Arch. Gen. Psychiatry 32: 749-761.
206. VON ZERSSEN, D., BERGER, M. and DOERR, P. (1984) Neuroendocrine dysfunction in subtypes of depression. In: Psychoneuroendocrine dysfunction in psychiatric and neurological illness: Influence of psychopharmacological agents, N.S. Shah and A.G. Donald (Eds.) Plenum Press, New York.
207. WEISS, J.M., GOODMAN, P.A., LOSITO, P.G., CORRIGAN, S., CHARRY, J.M. and BAILEY, W.H. (1981) Behavioral depression produced by an uncontrollable stressor: Relationship to norepinephrine, dopamine and serotonin levels in various region of rat brain. Brain Res. Rev. 3: 167-205.
208. WEISSE, C.S., PATO, C.N., McALLISTER, C.G., LITTMAN, R., BREIER, A., PAUL, S.M. and BAUM, A. (1990) Differential effects of controllable an uncontrollable acute stress on lymphocyte proliferation and leukocyte percentages in humans. Brain Behav. Immunity 4: 339-351.
209. WEIZMAN, R., LAOR, N., PODLISZEWSKI, E., NOTTI, I., DJALDETTI, M. and BESSLER, H. (1994) Cytokine production in major depressed patients before and after clomipramine treatment. Biol. Psychiatry 35: 42-47.
210. WOLFE, B.B., HARDEN, T.K., SPORN, J.R. and MOLINOFF, P.B. (1978) Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J. Pharmacol. Exp. Ther. 207: 446-457.
211. WYATT, R.J., PORTNOY, B. and KUPFER, D.J. (1971) Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch. Gen. Psychiatry 24: 65-70.
212. YOSHIMATSU, H., OOMURA, Y., KATAFUCHI, T., NIIJIM, A. and SATO, A. (1985) Lesions of the ventromedial hypothalamic nucleus enhance sympatho-adrenal function. Brain Res. 339:390-392.
213. YOUNG, J.B., ROSA, R.M. and LANDSBERG, L. (1984) Dissociation of sympathetic nervous system and adrenal medullary responses. Am. J. Physiol. 247: E35-E40.
214. ZIEGLER, M.G., LAKE, C.R. and WOOD, J.H. (1977) Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood cerebrospinal fluid barrier for NE. J. Neurochem. 28: 677-679.
215. ZIMMERMAN, M., CORYELL, W. and PFOHL, B. (1985) The categorical and dimensional models of endogenous depression. J. Affect. Dis. 9: 181-186.